勘误：原发性开角型青光眼或高眼压症患者中使用的无防腐剂与含苯扎氯铵防腐剂的拉坦前列素眼药水：一项美国3期临床试验[勘误]
Erratum: Preservative-Free versus Benzalkonium Chloride-Preserved Latanoprost Ophthalmic Solution in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Phase 3 US Clinical Trial [Corrigendum].
出版信息
Clin Ophthalmol. 2023 Sep 19;17:2763-2764. doi: 10.2147/OPTH.S438911. eCollection 2023.
Abstract
[This corrects the article DOI: 10.2147/OPTH.S414015.].
摘要
[本文更正了文章的数字对象标识符：10.2147/OPTH.S414015。]
相似文献
1
Erratum: Preservative-Free versus Benzalkonium Chloride-Preserved Latanoprost Ophthalmic Solution in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Phase 3 US Clinical Trial [Corrigendum].
Clin Ophthalmol. 2023 Sep 19;17:2763-2764. doi: 10.2147/OPTH.S438911. eCollection 2023.
2
Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension.
J Glaucoma. 2019 Jun;28(6):498-506. doi: 10.1097/IJG.0000000000001248.
3
Preservative-free versus preserved latanoprost eye drops in patients with open-angle glaucoma or ocular hypertension.
Curr Med Res Opin. 2016 Aug;32(8):1457-63. doi: 10.1080/03007995.2016.1202818. Epub 2016 Jun 25.
4
Preservative-Free versus Benzalkonium Chloride-Preserved Latanoprost Ophthalmic Solution in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Phase 3 US Clinical Trial.
Clin Ophthalmol. 2023 Sep 1;17:2575-2588. doi: 10.2147/OPTH.S414015. eCollection 2023.
5
Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost.
Clin Ophthalmol. 2010 Nov 3;4:1253-61. doi: 10.2147/OPTH.S14113.
6
Efficacy and safety of benzalkonium chloride-free fixed-dose combination of latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.
Clin Ophthalmol. 2014 Jun 28;8:1241-52. doi: 10.2147/OPTH.S64584. eCollection 2014.
7
Ocular surface status in glaucoma and ocular hypertension patients with existing corneal disorders switched from latanoprost 0.005% to tafluprost 0.0015%: comparison of two prostaglandin analogues with different concentrations of benzalkonium chloride.
Clin Exp Ophthalmol. 2018 Dec;46(9):1028-1034. doi: 10.1111/ceo.13329. Epub 2018 Jun 26.
8
Preservative-free latanoprost eye drops in patients with primary open-angle glaucoma/ocular hypertension.
Clin Drug Investig. 2014 Jul;34(7):521-8. doi: 10.1007/s40261-014-0203-4.
9
Objective ocular surface tolerance in patients with glaucoma treated with topical preserved or unpreserved prostaglandin analogues.
Eur J Ophthalmol. 2019 Nov;29(6):645-653. doi: 10.1177/1120672118805877. Epub 2018 Oct 10.
10
Efficacy and safety of newly developed preservative-free latanoprost 0.005% eye drops versus preserved latanoprost 0.005% in open angle glaucoma and ocular hypertension: 12-week results of a randomized, multicenter, controlled phase III trial.
Int J Ophthalmol. 2021 Oct 18;14(10):1539-1547. doi: 10.18240/ijo.2021.10.10. eCollection 2021.
Zotero 插件